Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | CGS Administrators | MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis | New policy |
| Aug 2, 2026 | CGS Administrators | Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH) | New policy |
| Aug 2, 2026 | CGS Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | Codes changed |
| Aug 2, 2026 | CGS Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | New policy |
| Aug 2, 2026 | CGS Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | Codes changed |
| Aug 2, 2026 | CGS Administrators | Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Solid Organ Allograft Rejection | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Solid Organ Allograft Rejection | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Solid Organ Allograft Rejection | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Solid Organ Allograft Rejection | New policy |
| Aug 2, 2026 | CGS Administrators | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | Codes changed |
| Aug 2, 2026 | CGS Administrators | Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | New policy |
| Aug 2, 2026 | CGS Administrators | Intervertebral Disc Repair | Codes changed |
| Aug 2, 2026 | CGS Administrators | Intervertebral Disc Repair | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | New policy |
| Aug 2, 2026 | CGS Administrators | Botulinum Toxin Injections | Codes changed |
| Aug 2, 2026 | CGS Administrators | Botulinum Toxin Injections | New policy |
| Aug 2, 2026 | CGS Administrators | Botulinum Toxin Injections | Codes changed |
| Aug 2, 2026 | CGS Administrators | Botulinum Toxin Injections | New policy |
| Aug 2, 2026 | CGS Administrators | Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) | Codes changed |
| Aug 2, 2026 | CGS Administrators | Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA) | New policy |
| Aug 2, 2026 | CGS Administrators | Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) | Codes changed |
| Aug 2, 2026 | CGS Administrators | Minimally Invasive Arthrodesis of the Sacroiliac Joint (SIJ) | New policy |
| Aug 2, 2026 | CGS Administrators | Cervical Fusion | Codes changed |
| Aug 2, 2026 | CGS Administrators | Cervical Fusion | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy | New policy |
| Aug 2, 2026 | CGS Administrators | Trigger Point Injections (TPI) | Codes changed |
| Aug 2, 2026 | CGS Administrators | Trigger Point Injections (TPI) | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers | Codes changed |
| Aug 2, 2026 | CGS Administrators | MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers | New policy |
| Aug 2, 2026 | CGS Administrators | Urinary Biomarkers for Chronic Pain Management | Codes changed |
| Aug 2, 2026 | CGS Administrators | Urinary Biomarkers for Chronic Pain Management | New policy |
| Aug 2, 2026 | CGS Administrators | MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma | New policy |
| Aug 2, 2026 | CGS Administrators | Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound | Codes changed |
| Aug 2, 2026 | CGS Administrators | Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound | New policy |
| Aug 2, 2026 | CGS Administrators | Positron Emission Tomography (PET) Scan for Inflammation and Infection | Codes changed |
| Aug 2, 2026 | CGS Administrators | Positron Emission Tomography (PET) Scan for Inflammation and Infection | New policy |
| Aug 2, 2026 | CGS Administrators | Cosmetic and Reconstructive Surgery | Codes changed |
| Aug 2, 2026 | CGS Administrators | Cosmetic and Reconstructive Surgery | New policy |
| Aug 2, 2026 | CGS Administrators | Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin | Codes changed |
| Aug 2, 2026 | CGS Administrators | Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin | New policy |